883 filings
Page 3 of 45
DEFA14A
kj3c179zwlp8v 6c3vj
1 May 23
Additional proxy soliciting materials
8:02am
D
uvlpvka2g144qyy76n
31 Mar 23
$25.00 mm in equity / options, sold $25.00 mm, 17 investors
11:30am
8-K
3cf1 ez4l
29 Mar 23
Delcath Systems Announces up to $85 Million Financing
9:45pm
8-K
fslk7dq
27 Mar 23
Regulation FD Disclosure
9:09pm
8-K
q0lvmfqup5rbyhwx8
27 Mar 23
Delcath Systems Announces up to $85 Million Financing
4:32pm
424B5
fv9xv2nl
27 Feb 23
Prospectus supplement for primary offering
4:58pm
8-K
bp5v3x89 ft9knrti3
24 Feb 23
Other Events
6:06am
8-K
7mcj97sc
14 Feb 23
Delcath Systems Announces New Drug Application Resubmission for HEPZATO Kit
10:58am
8-K
x5mo zfxrcva253ab4os
23 Jan 23
Other Events
7:01am
EFFECT
xvfn1ecdqw9 tmfucn
23 Jan 23
Notice of effectiveness
12:15am
424B3
pyalx4ldvkf 2bc
20 Jan 23
Prospectus supplement
4:38pm
CORRESP
copyg
18 Jan 23
Correspondence with SEC
12:00am
UPLOAD
842bwi8gno hfgr
17 Jan 23
Letter from SEC
12:00am
8-K
erm3a5l qfmi5h
10 Jan 23
Other Events
4:12pm
8-K
x9ctr56le0jtyfxax
3 Jan 23
Regulation FD Disclosure
4:17pm
SC 13D/A
fv9dltnq
21 Dec 22
DELCATH SYSTEMS / Rosalind Advisors ownership change
12:17pm